Navigation Links
Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis
Date:11/25/2009

HOUSTON - Two signaling pathways essential to normal human development - the Wnt/Wingless (Wnt) and epidermal growth factor receptor (EGFR) pathways - interact in ways that can promote tumor cell invasion and metastasis, researchers from The University of Texas M. D. Anderson Cancer Center report in the Nov. 25 issue of Molecular Cell.

This newly characterized interaction involves three signaling components known to correlate with invasive cancer - activation of EGFR, elevated protein kinase CK2 activity, and increased beta-catenin - T-cell factor/lymphoid enhancer factor (TCF/LEF-1) transcriptional activity.

"These findings highlight the importance of Wnt-independent and non-canonical activation of beta-catenin in tumor development," said senior author Zhimin Lu, MD, PhD, an associate professor in M. D. Anderson's Department of Neuro-Oncology. They also open up new possibilities for biomarkers that indicate prognosis or guide treatment.

Wnt Signaling and Cell-to-Cell Adhesion

Cell signaling is an intricate and precise process that enables cells to grow, differentiate (become specialized) and ultimately die (apoptosis). This orderly process is responsible for the normal development of organs and tissues. Alterations in the signaling within cells and between cells, however, can disrupt the cell-to-cell contact that helps keeps tumor cells in place. Loss of cell-to-cell contact leads to tumor cell migration, invasion and metastasis.

The Wnt signaling pathway plays a critical role in cell development, proliferation and differentiation. Mutations in this important pathway leading to the activation of beta-catenin are responsible for many types of cancer, including colon cancer. However, beta-catenin can also be activated in a mutation-independent manner in other cancers.

A key component of the Wnt pathway, beta-catenin combines with alpha-catenin and regulates cell-cell adhesion. It also interacts with alpha-catenin in the nucleus.

The alpha-catenin component of this beta-catenin/alpha-catenin complex has an inhibitory effect on beta-catenin that helps keep tumor cell migration and invasion in check. This inhibition is lost, however, when the EGFR pathway is activated. Upon activation, beta-catenin becomes untethered from alpha-catenin and translocates to the cell nucleus, where it increases expression of key target genes involved in tumor cell invasion and metastasis.

New Pathway Regulates Beta-Catenin Transactivation

The M. D. Anderson-led team made a surprising discovery: Beta-catenin also can travel to the nucleus via activation of the EGFR pathway-and it does so independently of Wnt signaling or mutations. The newly described pathway disrupts the beta-catenin/alpha catenin complex through an EGFR-extracellular receptor kinase (ERK)-protein kinase CK2- phosphorylation cascade. The investigators noted that this cascade culminates in the phosphorylation of alpha-catenin and ultimately promotes beta-catenin activation in the nucleus and subsequent tumor cell invasion.

The researchers found evidence of the newly identified pathway's clinical relevance when they examined human glioblastoma specimens. Specifically, levels of alpha-catenin phosphorylation correlated with levels of ERK activity and with grades of malignancy.

"Taken together, these findings demonstrate the importance of this pathway in tumor formation and progression," Dr. Lu said, "and they reveal potential markers for prognosis and therapeutics." Dr. Lu's lab is currently identifying genes downstream from beta-catenin that may be instrumental in tumor progression.

This research was supported by an American Cancer Society Research Scholar Award and grants from the Brain Tumor Society and Phi Beta Psi Sorority, an institutional research grant from M. D. Anderson Cancer Center; and a National Cancer Institute grant, all awarded to Lu.


'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Related medicine news :

1. Angioplasty Outcomes May Vary Little Between Hospitals
2. Experts Examine Possible Links Between Climate Change and Infectious Disease Transmission
3. American College of Cardiology/American Heart Association Comment on the FDA Public Health Advisory Regarding a Drug Interaction Between Clopidogrel and Omeprazole
4. K-State researchers studying link between climate change and cattle nutritional stress
5. Connection between depression and osteoporosis detailed by Hebrew University researchers
6. Researchers discover links between city walkability and air pollution exposure
7. Intervals between lung cancer diagnosis and treatment displays a health care disparity
8. Study reveals possible link between IBD therapy and skin cancer
9. New studies explore connection between high stress jobs and GI disorders
10. Pitt study shows linkage between teen girls weight and sexual behavior
11. Gastroenterologists explore relationship between bacteria in the gut and breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... 2016  Collagen Matrix, Inc., ("Collagen Matrix") the ... of collagen and mineral based medical devices for ... Bill Messer has joined the company as ... the growing portfolio of oral surgery, neurosurgery, orthopaedic ... joins the Collagen Matrix executive team as an ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
Breaking Medicine Technology: